BR112015010118A2 - material de sílica poroso para uso como um ingrediente ativo farmacêutico ou dietético - Google Patents
material de sílica poroso para uso como um ingrediente ativo farmacêutico ou dietéticoInfo
- Publication number
- BR112015010118A2 BR112015010118A2 BR112015010118A BR112015010118A BR112015010118A2 BR 112015010118 A2 BR112015010118 A2 BR 112015010118A2 BR 112015010118 A BR112015010118 A BR 112015010118A BR 112015010118 A BR112015010118 A BR 112015010118A BR 112015010118 A2 BR112015010118 A2 BR 112015010118A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical
- silica material
- active ingredient
- porous silica
- range
- Prior art date
Links
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 235000005911 diet Nutrition 0.000 title 1
- 230000000378 dietary effect Effects 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 239000000377 silicon dioxide Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/12—Surface area
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/14—Pore volume
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2006/00—Physical properties of inorganic compounds
- C01P2006/16—Pore diameter
- C01P2006/17—Pore diameter distribution
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Silicon Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261723019P | 2012-11-06 | 2012-11-06 | |
| PCT/EP2013/073200 WO2014072363A1 (en) | 2012-11-06 | 2013-11-06 | A porous silica material for use as a pharmaceutical or dietary active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112015010118A2 true BR112015010118A2 (pt) | 2017-07-11 |
Family
ID=49639855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112015010118A BR112015010118A2 (pt) | 2012-11-06 | 2013-11-06 | material de sílica poroso para uso como um ingrediente ativo farmacêutico ou dietético |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10695294B2 (enExample) |
| EP (2) | EP3892285A3 (enExample) |
| JP (2) | JP6421124B2 (enExample) |
| CN (2) | CN105188720A (enExample) |
| AU (1) | AU2013343565B2 (enExample) |
| BR (1) | BR112015010118A2 (enExample) |
| CA (3) | CA3024640A1 (enExample) |
| CY (1) | CY1124471T1 (enExample) |
| DK (1) | DK2916852T3 (enExample) |
| ES (1) | ES2878017T3 (enExample) |
| HR (1) | HRP20211036T1 (enExample) |
| HU (1) | HUE055017T2 (enExample) |
| IL (1) | IL238538B (enExample) |
| LT (1) | LT2916852T (enExample) |
| PH (1) | PH12015501010B1 (enExample) |
| PL (1) | PL2916852T3 (enExample) |
| PT (1) | PT2916852T (enExample) |
| SI (1) | SI2916852T1 (enExample) |
| WO (1) | WO2014072363A1 (enExample) |
| ZA (1) | ZA201502979B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013343565B2 (en) | 2012-11-06 | 2018-07-26 | Sigrid Therapeutics Ab | A porous silica material for use as a pharmaceutical or dietary active ingredient |
| TWI614017B (zh) | 2012-12-21 | 2018-02-11 | 財團法人國家衛生研究院 | 包含中孔洞矽奈米粒子之組成物的用途 |
| EP3651789A4 (en) * | 2017-07-13 | 2021-05-26 | Carnegie Mellon University | METHOD OF INCREASING EPITHELIAL PERMEABILITY USING NANOPARTICLES |
| EA202091351A1 (ru) * | 2017-12-13 | 2020-09-15 | Л.И.Ко.Райс С.Р.Л. | Комплекс лактоферрина и диоксида кремния, способ получения и композиции для гигиены полости рта |
| GB201803363D0 (en) | 2018-03-01 | 2018-04-18 | Sigrid Therapeutics Ab | New materials and uses thereof |
| WO2020212418A1 (en) * | 2019-04-15 | 2020-10-22 | Nanologica Ab | Empty porous particles for use in treatment, prevention and/or postponement of degeneration of neurodegenerative diseases, neurons and glia. |
| CN110314151B (zh) * | 2019-08-02 | 2020-06-02 | 深圳国佳产业基金管理有限公司 | 医用介孔二氧化硅材料及其应用 |
| CN114729263A (zh) * | 2019-09-30 | 2022-07-08 | 零点火技术股份有限公司 | 隔热阻燃材料及其制造方法 |
| JP7578945B2 (ja) * | 2020-10-27 | 2024-11-07 | 信越化学工業株式会社 | イミダゾールシラン処理シリカからなる胆汁酸吸着剤 |
| CN114195885B (zh) * | 2022-01-12 | 2024-04-26 | 杭州隆基生物技术有限公司 | 一种单克隆抗体组合物提纯方法 |
| CN118871077A (zh) | 2022-02-04 | 2024-10-29 | 西格丽德治疗公司 | 包含多孔二氧化硅颗粒的口腔护理组合物 |
| JP2025119063A (ja) | 2022-04-28 | 2025-08-14 | 日本たばこ産業株式会社 | 無機多孔質材料を含む口腔用組成物 |
| GB202212240D0 (en) | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New formulations and medical uses thereof |
| GB202212239D0 (en) | 2022-08-23 | 2022-10-05 | Sigrid Therapeutics Ab | New dietary supplements |
| CN116747321B (zh) * | 2023-06-14 | 2025-09-05 | 厦门君德医药科技有限公司 | 一种接枝改性的介孔二氧化硅及其制备方法和应用 |
| GB202312179D0 (en) | 2023-08-09 | 2023-09-20 | Sigrid Therapeutics Ab | New compositions and uses |
| GB202312176D0 (en) | 2023-08-09 | 2023-09-20 | Sigrid Therapeutics Ab | New uses and methods |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4185088A (en) | 1977-02-17 | 1980-01-22 | Merck & Co., Inc. | Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants |
| US4180566A (en) * | 1978-05-15 | 1979-12-25 | W. R. Grace & Co. | Silica gel method of reducing blood lipid concentration |
| US4824672A (en) * | 1986-06-06 | 1989-04-25 | Hauser-Kuhrts, Inc. | Method and composition for reducing serum cholesterol |
| US5401466A (en) * | 1993-06-01 | 1995-03-28 | Miles Inc. | Device for the direct measurement of low density lipoprotein cholesterol |
| EP0778027A3 (de) | 1995-12-04 | 1998-04-01 | Helmut Univ.-Prof. Dr. Wachter | Verwendung von Kieselerde zur Herstellung von Arzneimitteln |
| EP0911078A1 (en) * | 1997-10-20 | 1999-04-28 | Hitachi Metals, Ltd. | Photocatalyst-supporting body and photocatalytic apparatus |
| DK1093370T3 (da) * | 1998-06-30 | 2006-05-22 | Takeda Pharmaceutical | Farmaceutisk præparat til behandling af diabetes |
| WO2001012221A1 (en) * | 1999-08-16 | 2001-02-22 | Henceforth Hibernia, Inc. | Therapeutic and prophylactic compositions including catalytic biomimetic solids and methods to prepare and use them |
| RU2241462C2 (ru) | 2000-07-28 | 2004-12-10 | Ф. Хоффманн-Ля Рош Аг | Новая фармацевтическая композиция |
| US7074440B2 (en) * | 2002-05-01 | 2006-07-11 | Rulin Xiu | Compositions and methods for body weight loss |
| JP2004345895A (ja) * | 2003-05-21 | 2004-12-09 | Ajinomoto Co Inc | メソポーラスシリカ及びその製造方法 |
| JP2005289853A (ja) * | 2004-03-31 | 2005-10-20 | Ajinomoto Co Inc | 経口リン酸吸着剤 |
| GB0515353D0 (en) | 2005-07-27 | 2005-08-31 | Psimedica Ltd | Food |
| KR100857411B1 (ko) | 2006-07-21 | 2008-09-08 | 한올제약주식회사 | 리파아제 저해제의 경구 투여용 방출조절 약학 제제 및이의 제조 방법 |
| CN101939258B (zh) | 2008-02-11 | 2014-05-14 | 纳诺洛吉卡股份公司 | 中孔材料的制造方法、这样生产的材料以及中孔材料的用途 |
| TW200936130A (en) * | 2008-02-26 | 2009-09-01 | Lundbeck & Co As H | Uses of indane compounds |
| EP2271358B1 (en) * | 2008-03-25 | 2018-11-21 | Amarantus Therapeutics, Inc. | use of mesencephalic astrocyte-derived neurotrophic factor for treating Parkinson's disease |
| JP2010065023A (ja) * | 2008-08-14 | 2010-03-25 | Lion Corp | 脂溶性ビタミンおよび／または脂溶性色素含有粉体 |
| EP2349336B1 (en) * | 2008-10-28 | 2017-11-22 | Agency For Science, Technology And Research | Mesoporous material excipients for poorly aqueous soluble ingredients |
| DE102009026686A1 (de) * | 2009-06-03 | 2010-12-23 | Airbus France | Anordnung zum Blitzschutz einer elektronischen Einheit |
| EP2547733A1 (en) | 2010-03-17 | 2013-01-23 | Nanologica AB | Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof |
| ES2768229T3 (es) * | 2010-07-06 | 2020-06-22 | Nanologica Ab | Método mejorado para diferenciación de células madre in vivo mediante la administración de morfógenos con sílice mesoporosa y principios activos farmacéuticos correspondientes |
| GB201212866D0 (en) | 2012-07-20 | 2012-09-05 | Formac Pharmaceuticals Nv | Dry granulates of mesoporous silica powders |
| AU2013343565B2 (en) | 2012-11-06 | 2018-07-26 | Sigrid Therapeutics Ab | A porous silica material for use as a pharmaceutical or dietary active ingredient |
| EP2919903B1 (en) | 2012-11-14 | 2020-07-22 | W.R. Grace & CO. - CONN. | Compositions containing a biologically active material and a non-ordered inorganic oxide |
| TWI614017B (zh) | 2012-12-21 | 2018-02-11 | 財團法人國家衛生研究院 | 包含中孔洞矽奈米粒子之組成物的用途 |
-
2013
- 2013-11-06 AU AU2013343565A patent/AU2013343565B2/en active Active
- 2013-11-06 CN CN201380069421.3A patent/CN105188720A/zh active Pending
- 2013-11-06 PL PL13795191T patent/PL2916852T3/pl unknown
- 2013-11-06 SI SI201331885T patent/SI2916852T1/sl unknown
- 2013-11-06 EP EP21162691.6A patent/EP3892285A3/en not_active Withdrawn
- 2013-11-06 HU HUE13795191A patent/HUE055017T2/hu unknown
- 2013-11-06 LT LTEP13795191.9T patent/LT2916852T/lt unknown
- 2013-11-06 PH PH1/2015/501010A patent/PH12015501010B1/en unknown
- 2013-11-06 ES ES13795191T patent/ES2878017T3/es active Active
- 2013-11-06 CA CA3024640A patent/CA3024640A1/en not_active Abandoned
- 2013-11-06 BR BR112015010118A patent/BR112015010118A2/pt not_active Application Discontinuation
- 2013-11-06 DK DK13795191.9T patent/DK2916852T3/da active
- 2013-11-06 EP EP13795191.9A patent/EP2916852B1/en active Active
- 2013-11-06 JP JP2015540176A patent/JP6421124B2/ja active Active
- 2013-11-06 PT PT137951919T patent/PT2916852T/pt unknown
- 2013-11-06 WO PCT/EP2013/073200 patent/WO2014072363A1/en not_active Ceased
- 2013-11-06 CN CN202110214365.4A patent/CN113069467A/zh active Pending
- 2013-11-06 CA CA2890171A patent/CA2890171C/en active Active
- 2013-11-06 US US14/440,784 patent/US10695294B2/en active Active
- 2013-11-06 HR HRP20211036TT patent/HRP20211036T1/hr unknown
-
2015
- 2015-04-30 ZA ZA2015/02979A patent/ZA201502979B/en unknown
- 2015-04-30 IL IL238538A patent/IL238538B/en active IP Right Grant
-
2018
- 2018-10-15 JP JP2018194145A patent/JP6752858B2/ja active Active
- 2018-11-15 CA CA3024460A patent/CA3024460A1/fr active Pending
-
2020
- 2020-06-26 US US16/913,533 patent/US12121612B2/en active Active
-
2021
- 2021-07-13 CY CY20211100628T patent/CY1124471T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015010118A2 (pt) | material de sílica poroso para uso como um ingrediente ativo farmacêutico ou dietético | |
| CL2007002635A1 (es) | Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion. | |
| CL2013001339A1 (es) | Compuestos derivados heterociclicos condensados, con actividad antiviral; composicion farmaceutica que los comprende; y su uso para la prevencion o tratamiento de la infeccion de vih. | |
| WO2011133868A3 (en) | Conformationally restricted dinucleotide monomers and oligonucleotides | |
| UY31079A1 (es) | Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitógenos | |
| GT201200321A (es) | Derivados de heteroaril imidazolona como inhibidores de jak | |
| GT201200207A (es) | Derivados de imidazopiridina como inhibidores de jak | |
| CL2015001916A1 (es) | Derivados de pirimidona y su uso en el tratamiento, mejora o prevención de una enfermedad viral. | |
| CL2013003805A1 (es) | Combinación que comprende un primer agente que es un inhibidor de cinasa 4 dependiente de ciclina o cinasa 6 dependiente de ciclina (cdk4/6) de fórmula a y un segundo agente que es un inhibidor de pi3 cinasa de fórmula b1 o b2; uso para tratar cáncer. | |
| UY31209A1 (es) | Uso de homo y copolimeros para la estabilización de formulaciones de principios activos | |
| DOP2013000192A (es) | Compuestos y composiciones como inhibidores de la trk | |
| BR112015020118A2 (pt) | derivados de 2-aminopirimidina para o tratamento de infecções virais | |
| ECSP12012042A (es) | Derivados de pirazol como inhibidores de jak | |
| CO6300844A2 (es) | Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa | |
| UY31080A1 (es) | Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis | |
| ECSP11010995A (es) | Compuestos de multiheteroarilo como inhibidores de prostaglandina d sintasa hematopoyética y su uso para tratar enfermedades mediadas por prostaglandina d2 | |
| WO2013128402A3 (en) | Porous inorganic body | |
| BR112015013859A2 (pt) | corpo de carbono ferromagnético, processos para a produção de um corpo de carbono ferromagnético e de um corpo de carbono, uso de um corpo de carbono ferromagnético, e, catalisador | |
| ECSP088745A (es) | Derivados sustituidos de cromanol y su uso | |
| DOP2014000252A (es) | (R)-Nifuratel, su Uso para el Tratamiento de Infecciones y Síntesis de (R) y (S)-Nifuratel | |
| CL2007002862A1 (es) | Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha. | |
| CL2013003700A1 (es) | Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico. | |
| BR112015005796A2 (pt) | composição aquosa de revestimento, método para fornecer um revestimento, e, revestimento | |
| BR112016005589A8 (pt) | composição farmacêutica líquida, e, uso da mesma | |
| BR112015023878A2 (pt) | composto, composição farmacêutica, e, uso de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |